Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Lymphoma

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 58 articles: HTML format Text format

Single Articles

January 2010
1. PERALES MA , Jenq R, Goldberg JD, Wilton AS, et al
   Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
   Bone Marrow Transplant. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. GERTZ MA , Wolf RC, Micallef IN, Gastineau DA, et al
   Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma.
   Bone Marrow Transplant. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
3. KURUVILLA J , Pintilie M, Stewart D, Lachance S, et al
   Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group.
   Bone Marrow Transplant. 2009.
   PubMed     Text format     Related articles   
   
   
   
4. SAUTER C , Rausen AR, Barker JN
   Successful unrelated donor cord blood transplantation for adult sickle cell disease and Hodgkin lymphoma.
   Bone Marrow Transplant. 2009.
   PubMed     Text format     Related articles   
   
   
   
5. MUSSO M , Scalone R, Marcacci G, Lanza F, et al
   Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.
   Bone Marrow Transplant. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
6. MAGNI M , Di Nicola M, Carlo-Stella C, Devizzi L, et al
   Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.
   Bone Marrow Transplant. 2009.
   PubMed     Text format     Related articles   
   
   
   
7. KALOYANNIDIS P , Zomas A, Paterakis G, Vadikoliou C, et al
   GVL effect in plasmacytoid DC leukemia/lymphoma.
   Bone Marrow Transplant. 2009.
   PubMed     Text format     Related articles   
   
   
   September 2009
8. LEE SC , Kim SJ, Lee DH, Kim WS, et al
   Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma.
   Bone Marrow Transplant. 2009.
   PubMed     Text format     Related articles   
   
   
   
9. TAKACH S , Yang L, Ho J, Sabri E, et al
   Monoclonal B cells detected in autologous PBSC grafts from patients with classical Hodgkin lymphoma: impact on relapse and survival following transplantation.
   Bone Marrow Transplant. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. AKHTAR S , El Weshi A, Rahal M, Abdelsalam M, et al
    High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
11. FREYTES CO , Lazarus HM
    Second hematopoietic SCT for lymphoma patients who relapse after autotransplantation: another autograft or switch to allograft?
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
12. KEUNG YK , Levitan D, Zamkoff K, Hurd D, et al
    Should the concern of myelodysplastic syndrome affect the decision of auto-SCT in lymphoma?
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles   
    
    
    
13. BENJAMIN JE , Chen GL, Cao TM, Cao PD, et al
    Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. FRUEHAUF S , Ehninger G, Hubel K, Topaly J, et al
    Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. NUMATA A , Miyamoto T, Ohno Y, Kamimura T, et al
    Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. GOBBI PG , Valentino F, Lambelet P, Perfetti V, et al
    Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs.
    Bone Marrow Transplant. 2009;44:19-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
17. DUGAN MJ , Maziarz RT, Bensinger WI, Nademanee A, et al
    Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
18. AMBINDER RF
    The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. HUANG Q , Popplewell L, Lu Y, Slovak ML, et al
    Late onset of EBV-driven PTLD/Burkitt lymphoma/leukemia in a patient 10 years after allogeneic stem cell transplant for AML.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles   
    
    
    
20. SCHROEDER T , Zohren F, Saure C, Kobbe G, et al
    Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles   
    
    
    April 2009
21. HUNTER A , Mahendra P, Wilson K, Fields P, et al
    Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
    Bone Marrow Transplant. 2009;43:563-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. DE ASSIS RA , Kerbauy FR, Rodrigues M, Seguro FS, et al
    Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT.
    Bone Marrow Transplant. 2009;43:667-8.
    PubMed     Text format     Related articles   
    
    
    March 2009
23. BUHMANN R , Simoes B, Stanglmaier M, Yang T, et al
    Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion.
    Bone Marrow Transplant. 2009;43:383-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. MORITA R , Hashino S, Kubota K, Onozawa M, et al
    Donor cell-derived sarcoidosis after allogeneic BMT.
    Bone Marrow Transplant. 2009;43:507-8.
    PubMed     Text format     Related articles   
    
    
    February 2009
25. SOHN BS , Park I, Kim EK, Yoon DH, et al
    Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. MARCACCI G , Corazzelli G, Becchimanzi C, Arcamone M, et al
    DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles   
    
    
    
27. CUDILLO L , Cerretti R, Baliva G, De Angelis G, et al
    Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion.
    Bone Marrow Transplant. 2009;43:347-8.
    PubMed     Text format     Related articles   
    
    
    January 2009
28. HEIZMANN M , O'Meara AC, Moosmann PR, Heijnen IA, et al
    Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. ESCALON MP , Stefanovic A, Venkatraman A, Pereira D, et al
    Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. HOPPE BS , Moskowitz CH, Zhang Z, Maragulia JC, et al
    The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. MCCANN S , Schwenkglenks M, Bacon P, Einsele H, et al
    The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
    Bone Marrow Transplant. 2009;43:141-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
32. HICKS LK , Woods A, Buckstein R, Mangel J, et al
    Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
33. MAGNI M , Di Nicola M, Carlo-Stella C, Matteucci P, et al
    High-dose sequential chemotherapy and in vivo Rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles   
    
    
    
34. GUTIERREZ A , Caballero MD, Perez-Manga G, Rodriguez J, et al
    Hematopoietic SCT for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. HALLACK NETO AE , Dulley FL, Coelho Siqueira SA, Pracchia LF, et al
    Prognostic impact of diffuse large B-cell lymphoma subgroups in patients undergoing autologous SCT.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. CLAVIEZ A , Sureda A, Schmitz N
    Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008;42 Suppl 2:S16-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. FLESCH B , Miller J, Repp R, Ott S, et al
    Successful autologous hematopoietic progenitor cell transplantation in a patient with an isoantibody against CD36 (glycoprotein IV, Naka).
    Bone Marrow Transplant. 2008;42:489-91.
    PubMed     Text format     Related articles   
    
    
    
38. COSTA LJ , Rodriguez V, Porrata LF, Lacy MQ, et al
    Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
    Bone Marrow Transplant. 2008;42:497-8.
    PubMed     Text format     Related articles   
    
    
    
39. SUCAK GT , Yegin ZA, Ozkurt ZN, Aki SZ, et al
    The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
    Bone Marrow Transplant. 2008;42:461-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
40. HO J , Yang L, Banihashemi B, Martin L, et al
    Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. BACHANOVA V , Brunstein CG, Burns LJ, Miller JS, et al
    Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. YUSUF RZ , Dey B, Yeap BY, McAfee S, et al
    Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. COPELAN E , Pohlman B, Rybicki L, Kalaycio M, et al
    A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. KOLSTAD A , Tjonnfjord G, Jonsson V
    High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT.
    Bone Marrow Transplant. 2008;42:427-8.
    PubMed     Text format     Related articles   
    
    
    August 2008
45. BUSER A , Stern M, Arber C, Medinger M, et al
    Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. RAMADAN KM , Connors JM, Al-Tourah AJ, Song KW, et al
    Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. DAMON L , Damon LE, Gaensler K, Kaplan L, et al
    Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. AKHTAR S , Abdelsalam M, El Weshi A, Al Husseini H, et al
    High-dose chemotherapy and autologous stem cell transplantation for Hodgkin's lymphoma in the kingdom of Saudi Arabia: King Faisal specialist hospital and research center experience.
    Bone Marrow Transplant. 2008;42 Suppl 1:S37-S40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. MALONEY D
    Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
    Bone Marrow Transplant. 2008;42 Suppl 1:S35-S36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. BAZARBACHI A , Hatoum H, Mugharbel A, Otrock Z, et al
    Hematopoietic stem cell transplantation in Lebanon: first comprehensive report.
    Bone Marrow Transplant. 2008;42 Suppl 1:S96-S102.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. FRONKOVA E , Muzikova K, Mejstrikova E, Kovac M, et al
    B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL.
    Bone Marrow Transplant. 2008;42:187-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
52. SCHLEMMER F , Lagrange-Xelot M, Lacroix C, de La Tour R, et al
    Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2008;.
    PubMed     Text format     Related articles   
    
    
    June 2008
53. SAIRAFI D , Uzunel M, Remberger M, Ringden O, et al
    No impact of NOD2/CARD15 on outcome after SCT.
    Bone Marrow Transplant. 2008;41:961-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. CHUNDURI S , Dobogai LC, Peace D, Saunthararajah Y, et al
    Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
    Bone Marrow Transplant. 2008;41:935-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
55. LIM SH , Zhang Y, Burris C, Townsend M, et al
    Successful salvage with unrelated umbilical cord blood transplant for Hodgkin's disease relapsed following autologous stem cell transplant.
    Bone Marrow Transplant. 2008;.
    PubMed     Text format     Related articles   
    
    
    
56. KORNBLIT B , Masmas T, Madsen HO, Ryder LP, et al
    Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants.
    Bone Marrow Transplant. 2008;41:851-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. GRULLICH C , Bertz H, Spyridonidis A, Muller CI, et al
    A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
    Bone Marrow Transplant. 2008;41:845-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2007
58. BENSON DM JR , Smith MK, Krugh D, Devine SM, et al
    Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab.
    Bone Marrow Transplant. 2007;.
    PubMed     Text format     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: